Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Advent expands beauty portfolio with $165m Salt & Stone deal
Advent expands beauty portfolio with $165m Salt & Stone deal Advent has agreed to acquire a majority stake in Salt & Stone, as the private equity firm expands its exposure to high-growth premium beauty and wellness brands. The Los Angeles-based body care...
Apollo commits $3.7bn to NSG in largest Japan private equity investment
Apollo commits $3.7bn to NSG in largest Japan private equity investment Apollo-managed funds have agreed to acquire Nippon Sheet Glass in a transaction valued at approximately $3.7bn, marking the firm’s largest private equity investment in Japan to date. The deal...
CVC and Silver Lake test $6.7bn RAC IPO as investor outreach begins
CVC and Silver Lake test $6.7bn RAC IPO as investor outreach begins CVC Capital Partners and Silver Lake have begun investor outreach for a potential London IPO of RAC, as the private equity firms explore a listing that could value the business at around $6.7bn,...